 | Up a level |
Van Emmenis, Lucie; Ku, Sheng-Yu; Gayvert, Kaitlyn; Branch, Jonathan R; Brady, Nicholas J; Basu, Subhasree; Russell, Michael; Cyrta, Joanna; Vosoughi, Aram; Sailer, Verena; Alnajar, Hussein; Dardenne, Etienne; Koumis, Elena; Puca, Loredana; Robinson, Brian D; Feldkamp, Michael D; Winkis, Annmarie; Majewski, Nathan; Rupnow, Brent; Gottardis, Marco M; ... (2023). The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer. Cancer research communications, 3(8), pp. 1447-1459. American Association for Cancer Research 10.1158/2767-9764.CRC-22-0491
Beltran, Himisha; Oromendia, Clara; Danila, Daniel C; Montgomery, Bruce; Hoimes, Christopher; Szmulewitz, Russell Z; Vaishampayan, Ulka; Armstrong, Andrew J; Stein, Mark; Pinski, Jacek; Mosquera, Juan M; Sailer, Verena; Bareja, Rohan; Romanel, Alessandro; Gumpeni, Naveen; Sboner, Andrea; Dardenne, Etienne; Puca, Loredana; Prandi, Davide; Rubin, Mark A.; ... (2019). A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers. Clinical cancer research, 25(1), pp. 43-51. American Association for Cancer Research 10.1158/1078-0432.CCR-18-1912
